Maribao, Kim Estila L.

HRN: 25-79-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/24/2025
12/31/2025
IV
750mg
Q6h
Hemolytic Anemia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines